ASCO 2024: vídeos e entrevistas
116 vídeos do ASCO 2024 publicados por ASCO, ASCO Podcasts, OncLive, Oncology Brothers, ecancer. Atualizado em 20/11/2026.
Exploring CAR T Cells in GI Cancers at ASCO24ASCO Podcasts · 19/02/2025 · 17:58
Key Insights from ASCO 2024ecancer · 24/01/2025 · 10:14 · apoio da indústria
Dr Mowery on Pembrolizumab Plus Radiation Therapy and Surgery in Soft Tissue SarcomaOncLive · 20/01/2025 · 2:35 · apoio da indústria
Dr Singer on the Efficacy of IO/TKI Doublets in Advanced RCCOncLive · 09/11/2024 · 2:56 · apoio da indústria
Personalizing Locoregional Treatment for Breast CancerASCO Podcasts · 17/10/2024 · 18:41
ASCO 2024 Applications in Gynecologic Oncology: Episode 4OncLive · 18/09/2024 · 1:58 · apoio da indústria
ASCO 2024 Applications in Gynecologic Oncology: Episode 3OncLive · 11/09/2024 · 1:34 · apoio da indústria
ASCO 2024 Applications in Gynecologic Oncology: Episode 2OncLive · 05/09/2024 · 2:02 · apoio da indústria
Dr Li on Cretostimogene Grenadenorepvec Plus Pembrolizumab in BCG-Unresponsive NMIBCOncLive · 29/08/2024 · 2:02 · apoio da indústria
ASCO 2024 Applications in Gynecologic Oncology: Episode 1OncLive · 28/08/2024 · 2:47 · apoio da indústria
Dr Linscott on the Need for Improved MRD Detection in High-Risk NMIBCOncLive · 23/08/2024 · 2:10 · apoio da indústria
Dr Trudel on the Significance of the DREAMM-7 and DREAMM-8 Trials in R/R Multiple MyelomaOncLive · 20/08/2024 · 1:29 · apoio da indústria
Dr Subbiah on Outcomes With Larotrectinib in TRK Fusion–Positive Solid TumorsOncLive · 20/08/2024 · 1:06 · apoio da indústria
Dr Yee on Neoadjuvant Datopotamab Deruxtecan Plus Durvalumab in Early-Stage Breast CancerOncLive · 20/08/2024 · 1:21 · apoio da indústria
How AI Can Improve Patient Identification and Recruitment for Clinical TrialsASCO Podcasts · 15/08/2024 · 18:20
Dr Llombart-Cussac on Prophylaxis for Neutropenia and Diarrhea in Advanced Breast CancerOncLive · 13/08/2024 · 1:06 · apoio da indústria
Dr Goodman on the Addition of CRT to Adjuvant Chemo in Pancreatic Head AdenocarcinomasOncLive · 12/08/2024 · 1:07 · apoio da indústria
Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple MyelomaOncLive · 12/08/2024 · 1:10 · apoio da indústria
DESTINY-Breast06 and A-BRAVE: Advances in Breast Cancer ResearchASCO Podcasts · 08/08/2024 · 15:12
Dr Linscott on Future Directions for utDNA Research in Bladder CancerOncLive · 08/08/2024 · 1:26 · apoio da indústria
Dr Bazhenova on Updated Data From the TRUST-I Trial of Taletrectinib in ROS1+ NSCLCOncLive · 08/08/2024 · 2:45 · apoio da indústria
Dr Uzzo on a Biomarker Analysis of the IMmotion010 Trial in RCCOncLive · 31/07/2024 · 2:47 · apoio da indústria
How to Enhance Early-Stage Breast Cancer SurvivorshipASCO Podcasts · 25/07/2024 · 18:48
Management of Stage III NSCLC Rapid UpdateASCO Podcasts · 23/07/2024 · 8:02
Putting Patients First: Common Sense in Cancer CareASCO Podcasts · 18/07/2024 · 25:45
Dr Garfall on Updated Safety Data for Teclistamab in R/R MyelomaOncLive · 18/07/2024 · 1:15 · apoio da indústria
Dr Sun on Managing TEAEs of Tisotumab Vedotin in Recurrent/Metastatic HSNCCOncLive · 17/07/2024 · 1:03 · apoio da indústria
Dr Rini on a Biomarker Analysis of KEYNOTE-426 Using Subtype Clustering RCCOncLive · 17/07/2024 · 1:18 · apoio da indústria
Dr Markman on the Association Between Obesity and Incidence of Endometrial CancerOncLive · 16/07/2024 · 1:08 · apoio da indústria
An Era of Promise for Cancer VaccinesASCO Podcasts · 10/07/2024 · 19:21
Dr Albigès on the Predictive and Prognostic Utility of KIM-1 in High-Risk RCCOncLive · 10/07/2024 · 1:32 · apoio da indústria
Dr Lin on the Efficacy and Safety of Taletrectinib in ROS1 Fusion+ NSCLCOncLive · 04/07/2024 · 2:39 · apoio da indústria
Dr O'Malley on Updates in Gynecologic Oncology at the 2024 ASCO Annual MeetingOncLive · 28/06/2024 · 2:20 · apoio da indústria
Dr Ramalingam on Updates in Lung Cancer Following the 2024 ASCO Annual MeetingOncLive · 28/06/2024 · 2:47 · apoio da indústria
GU Oncology Highlights From ASCO24ASCO Podcasts · 27/06/2024 · 35:27
Dr Parikh on Outcomes from the HERKULES-3 Trial in BRAF V600E–Mutant mCRCOncLive · 27/06/2024 · 1:16 · apoio da indústria
Top ASCO24 Abstracts That Could Revolutionize OncologyASCO Podcasts · 26/06/2024 · 27:33
ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant ...ecancer · 26/06/2024 · 2:26 · apoio da indústria
Enfortumab vedotin improves efficacy outcomes in locally advanced or metastatic urothelial cance...ecancer · 26/06/2024 · 2:31 · apoio da indústria
Adjuvant avelumab versus control does not significantly improve DFS but does improve OS in high-...ecancer · 26/06/2024 · 4:35 · apoio da indústria
Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-...ecancer · 26/06/2024 · 2:57 · apoio da indústria
Transoral surgery and neck dissection with deintensified risk-based post-operative management re...ecancer · 26/06/2024 · 5:00 · apoio da indústria
Immune therapy with belantamab mafodotin and elotuzumab shows encouraging safety profile and pre...ecancer · 26/06/2024 · 3:48 · apoio da indústria
Chemotherapy before and after surgery may be new standard treatment for some patients with oesop...ecancer · 26/06/2024 · 1:47 · apoio da indústria
Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...ecancer · 26/06/2024 · 4:33 · apoio da indústria
Teclistamab continues to demonstrate deep and durable responses in relapsed/refractory multiple ...ecancer · 26/06/2024 · 2:52 · apoio da indústria
ASCO 2024: Lung cancer roundupecancer · 26/06/2024 · 5:26 · apoio da indústria
Cancer advocacy and fundraising in Nigeriaecancer · 26/06/2024 · 5:30 · apoio da indústria
Neoadjuvant daromun is an effective and safe therapeutic option for resectable, locally advanced...ecancer · 26/06/2024 · 3:12 · apoio da indústria
Advanced epithelial ovarian cancer patients may safely avoid a lymphadenectomy without it impact...ecancer · 26/06/2024 · 5:00 · apoio da indústria
Atezolizumab versus placebo in combination with bevacizumab and non-platinum-based chemotherapy ...ecancer · 26/06/2024 · 6:36 · apoio da indústria
Addition of cabazitaxel to abiraterone/prednisone significantly prolonged PFS in extensive disea...ecancer · 26/06/2024 · 4:01 · apoio da indústria
Neoadjuvent ipilimumab plus nivolumab beneficial compared to adjuvent nivolumab in macroscopic, ...ecancer · 26/06/2024 · 2:57 · apoio da indústria
Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM...ecancer · 26/06/2024 · 4:40 · apoio da indústria
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-p...ecancer · 26/06/2024 · 4:41 · apoio da indústria
Neoadjuvant sacituzumab govitecan showed promising activity in muscle-invasive urothelial bladde...ecancer · 26/06/2024 · 4:34 · apoio da indústria
Results from first safety run-in demonstrate a manageable safety profile with early efficacy of ...ecancer · 26/06/2024 · 2:54 · apoio da indústria
Maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therap...ecancer · 26/06/2024 · 4:26 · apoio da indústria
Inavo, palbo plus fulv sees sustained benefit beyond disease progression in HER2‑negative locall...ecancer · 26/06/2024 · 4:11 · apoio da indústria
Adagrasib demonstrates improvement in PFS and ORR over docetaxel in patients with previously tre...ecancer · 26/06/2024 · 2:26 · apoio da indústria